TEST BANK For Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition by Woo & Wright, All Chapters Covered, Latest Edition

HlO M oARcPSD| 3 3274416
9




Test3Bank3for3Pharmacotherapeutics3for3Advanced3Practice3Nurse3Prescribers36th 3Edition

, 3
lO M oAR cPSD|




3 32744169




Pharmacotherapeutics3for3Advanced3Practice3Nurse3Prescribers36th3Edition3Woo3Robinson3Test3Bank


Chapter31.3The3Role3of3the3Nurse3Practitioner3

Multiple3Choice
Identify3the3choice3that3best3completes3the3statement3or3answers3the3question.


1. Nurse3practitioner3prescriptive3authority3is3regulated3 by:
1. The3National3Council3of3State3Boards3of3Nursing
2. The3U.S.3Drug3Enforcement3Administration
3. The3State3Board3of3Nursing3for3each3state
4. The3State3Board3of3Pharmacy

2. The3benefits3to3the3patient3of3having3an3Advanced3Practice3Registered3Nurse3(APRN) 3prescribe
r3include:
1. Nurses3know3more3about3Pharmacology3than3other3prescribers3because3they3take3i
t3both3in3their3basic3nursing3program3and3in3their3APRN3program.
2. Nurses3care3for3the3patient3from3a3holistic3approach3and3include3the3patient3i
n3decision3making3regarding3their3care.
3. APRNs3are3less3likely3to3prescribe3narcotics3and3other3controlled3substances.
4. APRNs 3are3able3to3prescribe3independently3in3all3states,3whereas3a3physician’
s3assistant3needs3to3have3a3physician3supervising3their3practice.
3. Clinical3judgment3in3prescribing3 includes:
1. Factoring3in3the3cost3to3the3patient3of3the3medication3prescribed
2. Always3prescribing3the3newest3medication3available3for3the3disease3process
3. Handing3out3drug3samples3to3poor3patients
4. Prescribing3all3generic3medications3to3cut3costs

4. Criteria3for3choosing3an3effective3drug3for3a3disorder3include:
1. Asking3the3patient3what3drug3they3think3would3work3best3for3them
2. Consulting3nationally3recognized3guidelines3for3disease3management
3. Prescribing3medications3that3are3available3as3samples3before3writing3a3prescription
4. Following3U.S.3Drug3Enforcement3Administration3guidelines3for3prescribing

5. Nurse3practitioner3practice3may3thrive3under3health-care3reform3because3 of:
1. The3demonstrated3ability3of3nurse3practitioners3to3control3costs3and3improve3patien
t3outcomes
2. The3fact3that3nurse3practitioners3will3be3able3to3practice3independently
3. The3fact3that3nurse3practitioners3will3have3full3reimbursement3under3health-
care3reform
4. The3ability3to3shift3accountability3for3Medicaid3to3the3state3level

, 3
lO M oAR cPSD|




3 32744169




Chapter31.3The3Role3of3the3Nurse3Practitioner3
Answer3Section

MULTIPLE3CHOICE

1.3ANS: 3 PTS: 1
2.3ANS: 2 PTS: 1
3.3ANS: 1 PTS: 1
4.3ANS: 2 PTS: 1
5.3ANS: 1 PTS: 1

Chapter32.3Review3of3Basic3Principles3of3Pharmacology3Mul

tiple3Choice
Identify3the3choice3that3best3completes3the3statement3or3answers3the3question.


3 1.3A3patient’s3nutritional3intake3and3laboratory3results3reflect3hypoalbuminemia.3This3is3critical3t
o3prescribing3because:
1. Distribution3of3drugs3to3target3tissue3may3be3affected.
2. The3solubility3of3the3drug3will3not3match3the3site3of3absorption.
3. There3will3be3less3free3drug3available3to3generate3an3effect.
4. Drugs3bound3to3albumin3are3readily3excreted3by3the3kidneys.

3 2.3Drugs3that3have3a3significant3first-pass3 effect:
1. Must3be3given3by3the3enteral3(oral)3route3only
2. Bypass3the3hepatic3circulation
3. Are3rapidly3metabolized3by3the3liver3and3may3have3little3if3any3desired3action
4. Are3converted3by3the3liver3to3more3active3and3fat-soluble3forms

3 3.3The3route3of3excretion3of3a3volatile3drug3will3likely3be3 the:
1. Kidneys
2. Lungs
3. Bile3and3feces
4. Skin

3 4.3Medroxyprogesterone3(Depo3Provera)3is3prescribed3intramuscularly3(IM)3to3create3a3storag
e3reservoir3of3the3drug.3Storage3reservoirs:
1. Assure3that3the3drug3will3reach3its3intended3target3tissue
2. Are3the3reason3for3giving3loading3doses
3. Increase3the3length3of3time3a3drug3is3available3and3active
4. Are3most3common3in3collagen3tissues

33 5.3The3NP3chooses3to3give3cephalexin3every383hours3based3on3knowledge3of3the3 drug’s:
1. Propensity3to3go3to3the3target3receptor
2. Biological3half-life
3. Pharmacodynamics
4. Safety3and3side3effects

, 3
lO M oAR cPSD|




3 32744169




3 6.3Azithromycin3dosing3requires3that3the3first3day’s3dosage3be3twice3those3of3the3other343days3of3t
he3prescription.3This3is3considered3a3loading3dose.3A3loading3dose:
1. Rapidly3achieves3drug3levels3in3the3therapeutic3range
2. Requires3four-3to3five-half-lives3to3attain
3. Is3influenced3by3renal3function
4. Is3directly3related3to3the3drug3circulating3to3the3target3tissues

3 7.3The3point3in3time3on3the3drug3concentration3curve3that3indicates3the3first3sign3of3a3therapeutic3effe
ct3is3the:
1. Minimum3adverse3effect3level
2. Peak3of3action